Biophore receives sub-licence from MPP to manufacture and market Molnupiravir
The company has received DCGI regulatory license for the Indian market, applicable for both API as well as the finished product
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biophore India Pharmaceuticals
Biophore applies for DCGI approval for emergency use of Aviptadil to treat COVID-19
The company informed that it will be commencing commercial production immediately after the approval is received
Biophore ramps up Made-In-India Favipiravir production for Covid-19
Biophore has received the DCGI license to manufacture the API in India and has been cleared for export as well